Results

Total Results: 911 records

Showing results for "measures".
Users also searched for: quality measures

901. Archived: Evidence Summary: Visual Impairment in Children Ages 1-5: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
     January 15, 2011 - No trial evaluated the effects of treatment on school performance or other measures of function. … No trial evaluated effects of treatment compared with no treatment on school performance or other measures … 22%); mixed anisometropia and strabismus 34/97 (35%) Fair a Converted from Snellen metric measures

902. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholerolemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
     August 09, 2016 - MAIN OUTCOMES AND MEASURES Myocardial infarction and ischemic stroke in adulthood; lipid concentrations … Outcomes No direct evidence supports a link between lipid concentrations or measures of atherosclerosis … .65,66 Reaching agree- ment on acceptable surrogate end points, such as CIMT and other atherosclerosis measures

903. Screening for Carotid Artery Stenosis: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSj5xRQc9DroH8gpUYsoFA
     December 01, 2007 - maintenance of comparable groups, important differential loss to follow-up or overall high loss to follow-up, measure … One meta-analysis noted that the measure- ment properties used among ultrasonography laboratories varied … The primary perioperative complica- tion measure in the studies was either death/stroke or death/stroke

904. Archived: Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-screening-july-2016
     July 26, 2016 - Main Outcomes and Measures: Melanoma incidence and mortality, harms from cancer screening, diagnostic … outcomes relating clinician skin examination to other risk factors (eg, sun-protection behaviors); or measures … differences in time to ascertainment of cancer outcomes that affect screening examination performance measures

905. U.S. Preventive Services Task Force Announces Addition of Three New Members: Experts in primary care, evidence-based medicine, and health disparities join the Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/2024-tf-new-members-bulletin.pdf
     January 01, 2024 - U.S. Preventive Services Task Force Announces Addition of Three New Members: Experts in primary care, evidence-based medicine, and health disparities join the Task Force 1 www.uspreventiveservicestaskforce.org U.S. Preventive Services Task Force Announces Addition of Three New Members Experts in primary …

906. Archived: Final Evidence Summary: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
     December 15, 2007 - between 1994 and 2000 on harms of carotid endarterectomy. 48 The primary perioperative complication measure

907. 6Ngc3Byq9Jeby Pwyvd6Or (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Ngc3byQ9jeBy_pwyvD6or
     September 01, 2014 - Absolute measures are more easily interpreted, show more directly relevant information, and better allow … Summary of Main Results of Meta-analyses Outcome Studies, n Participants*, n Effect Measure† Estimate … An assessment of clinically useful measures of the consequences of treatment. … Clinically useful measures of effect in binary anal- yses of randomized trials.

908. Archived: Evidence Summary (Pregnant and Postpartum Women): Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
     January 26, 2016 - Main Outcomes and Measures: Depression remission, prevalence, symptoms, and related measures of depression … recovery or response; sensitivity and specificity of selected screening measures to detect depression … Results were similar for 2 other continuous measures of depression symptom severity, but this trial did … The use of rating scales to identify post-natal depression. … Validation of two postpartum depression screening scales with a sample of First Nations and Métis women

909. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
     March 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication March 15, 2009 Recommendations made by the USPSTF are independent of t…

910. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
     March 01, 2009 - Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force Tracy Wolff, MD, MPH; Therese Miller, DrPH; and Stephen Ko, MD, MPH Background: Coronary heart dise…

911. PII: S0749-3797(01)00261-6 (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
     January 01, 2001 - 5 for interme- diate or health outcomes, respectively), and the associ- ation between intermediate measures … measured by a DNA probe) are often used in studies as indicators of efficacy; health out- comes are measures … Beware of surrogate outcome measures. Int J Tech Assess Health Care 1996;12:238–46. 20.